Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma

@article{Tilly2013Phase1S,
  title={Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma},
  author={Herv{\'e} Tilly and Franck Morschhauser and Gilles Salles and R-O Casasnovas and Pierre Feugier and T. J. Molina and Fabrice Jardin and Louis Terriou and Corrine Haioun and Bertrand Coiffier},
  journal={Leukemia},
  year={2013},
  volume={27},
  pages={252-255}
}
TD Buitenkamp, R Pieters, M Zimmermann, V de Haas, SM Richards, AJ Vora, CD Mitchell, C Schwab, CJ Harrison, AV Moorman, MM van den Heuvel-Eibrink and CM Zwaan Pediatric Oncology/Hematology, Erasmus MC–Sophia Children’s Hospital, Rotterdam, The Netherlands; Dutch Childhood Oncology Group, Den Haag, The Netherlands; Acute Myeloid Leukemia-Berlin-Frankfurt-Münster Study Group, Pediatric -Hematology/Oncology, Medical School Hannover, Hannover, Germany; Clinical Trial Service Unit, University of… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

A comprehensive review of lenalidomide in B-cell non-Hodgkin lymphoma.

Therapeutic advances in hematology • 2016
View 11 Excerpts
Highly Influenced

Follicular Lymphoma: The Role of the Tumor Microenvironment in Prognosis.

Journal of clinical and experimental hematopathology : JCEH • 2016

A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology • 2015
View 3 Excerpts

References

Publications referenced by this paper.
Showing 1-10 of 12 references

Lenalidomide plus rituximab a highly effective and well - tolerated biologic therapy in untreated indolent B - cell non - hodgkin lymphoma

N Fowler, FB Hagemeister, +3 authors M Fanale
Ann Oncol • 2011

Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's Lymphoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2009

Lenalidomide for the treatment of B-cell malignancies.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2008

Similar Papers

Loading similar papers…